Susceptibility to Radiation-Induced Breast Cancer Following Treatment for Hodgkin Lymphoma
Genetic variants associated with radiation-induced breast cancer include MYC-adjacent oncogene PVT1.
Lymphoma
LYMPHOMA ADVISOR
FEATURED CONTENT
-
-
Understanding the Limitations of CAR-T Cell Therapies
CAR-T’s inability to induce durable remissions in many patients is a barrier to the success of these adoptive cell therapies—but solutions are under way. -
Analysis Highlights Link Between Lymphoma and Glyphosate
EPA panelists, frustrated with the agency’s review process, publish their own analysis implicating the controversial herbicide’s role in non-Hodgkin lymphoma risk. -
BMT Societies Issue Recommendations on Posttransplant Maintenance in HL/NHL
Use of maintenance therapy as a therapeutic strategy in posttransplant patients with HL and NHL is increasing in frequency -
Predicting PD-1/PD-L1 Immunotherapy Responses
Finding biomarkers that can broadly and reliably predict immunotherapy outcomes for patients with cancer remains an elusive “holy grail,” said Dr Ott.
VIDEO SERIES
LYMPHOMA NEWS
Follicular Lymphoma With Extranodal Disease Only: When to Suspect Systemic Disease
Remodeled CD19 CAR Shows Clinical Benefit, Low Toxicity in B-Cell Lymphoma
Extranodal and Spleen Involvement Predict Outcomes in Follicular Lymphoma
Postchemo Radiation Tx May Benefit Some With Hodgkin Lymphoma
High 5-Year OS Rate for Children and Young Adults with Relapsed/Refractory Hodgkin Lymphoma Receiving Moderate-Dose Salvage RT
Want to read more?
Please login or register first to view this content.
Next post in Lymphoma
